Defining the sensitivity landscape of EGFR variants to tyrosine kinase inhibitors
Lei An, Yueqiang Wang, Guangyao Wu, Zhenxing Wang, Zeyuan Shi, chang liu, Chunli Wang, Ming Yi, Chenguang Niu, Shaofeng Duan, Xiaodong Li, Wenxue Tang, Kongming Wu, Shuqing Chen, Hongen Xu
Topics & Concepts
AfatinibGefitinibErlotinibEpidermal growth factor receptorOsimertinibBiologyEGFR inhibitorsExonCancer researchMutationGeneticsMolecular biologyGeneReceptorLung Cancer Treatments and MutationsMonoclonal and Polyclonal Antibodies ResearchBiochemical and Molecular Research